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Abstract
A mixture with essential and nonessential amino acids high in branched chain amino acids and
low in aromatic amino acids (Fischer solution), and another synthetic mixture of branched chain
amino acids containing 3 amino acids associated with the urea cycle (Hep-OU) were infused to
control subjects and patients with severe hepatic disease. Alterations in serum aminograms, blood
ammonia levels and electroencephalograms following the infusion were studied and compared
with those obtained by a commercially available amino acid mixture. Short-term or continuous
infusion of a commercially available amino acid solution to cirrhotic patients caused an increase
in methionine, phenylalanine and tyrosine and a decrease in branched chain amino acids. These
post-infusion results were similar to the patterns seen in hepatic encephalopathy. In cirrhotic
patients, infusion of Fischer solution which contains small quantities of methionine and pheny-
lalanine produced an increase in the concentrations of these 2 amino acids, probably because of
impaired utilization by the injured liver. No marked alterations in serum aminograms, however,
were observed in cirrhotic patients either immediately after, or 3 h after, the end of the Hep-OU
infusion. Reduction of methionine, tyrosine and phenylalanine levels and elevation of the molar
ratio of (valine+leucine+isoleucine) / (phenylalanine+tyrosine) were significant. The infusion of
Hep-OU to patients with liver cirrhosis or subacute hepatitis resulted in clinical and neurological
improvements and the restoration of the molar ratio of branched chain amino acids/aromatic amino
acids.
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Abstract. A mixture with essential and nonessential amino acids
high in branched chain amino acids and low in aromatic amino acids
(Fischer solution), and another synthetic mixture of branched chain
amino acids containing 3 amino acids associated with the urea cycle
(Hep-OU) were infused to control subjects and patients with severe
hepatic disease. Alterations in serum aminograms, blood ammonia
levels and electroencephalograms following the infusion were studied
and compared with those obtained by a commercially available amino
acid mixture. Short-term or continuous infusion of a commercially avail-
able amino acid solution to cirrhotic patients caused an increase in
methionine, phenylalanine and tyrosine and a decrease in branched
chain amino acids. These post-infusion results were similar to the pat-
terns seen in hepatic encephalopathy. In cirrhotic patients, infusion of
Fischer solution which contains small quantities of methionine and
phenylalanine produced an increase in the concentrations of these 2
amino acids, probably because of impaired utilization by the injured
liver. No marked alterations in serum aminograms, however, were
observed in cirrhotic patients either immediately after, or 3 h after, the
end of the Hep-OU infusion. Reduction of methionine, tyrosine and
phenylalanine levels and elevation of the molar ratio of (valine + leucine
+ isoleucine) / (phenylalanine + tyrosine) were significant. The infusion
of Hep-OU to patients with liver cirrhosis or subacute hepatitis resulted
in clinical and neurological improvements and the restoration of the
molar ratio of branched chain amino acids/aromatic amino acids.
Key words: serum amino acids, hepatic encephalopathy, liver cir-
rhosis, fulminant and subacute hepatitis, aromatic and
branched chain amino acids.
Hepatic failure is associated with considerable distortion in serum amino
acid levels; the levels of tyrosine, phenylalanine and methionine in serum being
elevated whereas those of branched chain amino acids are diminished (l). This
pattern of amino acid imbalance is thought to be of considerable importance
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to cerebral function in patients with hepatic disease (2). Munro et at. (3) sug-
gested that entry of tryptophan into the brain might be regulated by the concent-
rations of other neutral amino acids competing for cerebral uptake, notably
branched chain amino acids. The higher levels of insulin in the blood of patients
with advanced cirrhosis of the liver would promote excessive removal of branch-
ed chain amino acids by muscle, leading to a reduction of the competitive action
of branched chain amino acids on the entry of tryptophan into the brain (3). It
is therefore of great importance to normalize the levels of branched chain amino
acids in hepatic disease.
Patients with advanced cirrhosis of the liver are frequently limited to less
than 40 g daily dietary protein or completely fasted because of the high ammonia
levels in the blood or the upper gastrointestinal bleeding. The malnutrition in
patient with cirrhosis is accompanied by a catabolic state with negative nitrogen
balance. This results in hepatic encephalopathy probably through the increased
formation of various amines and degraded metabolites of protein (4). These
protein depletions are a major problem in the treatment of cirrhotic patients.
The provision of adequate nutrition by mouth is made difficult by protein intol-
erance. Techniques for intravenous hyperalimentation with an adequate amino
acid solution can safely provide large amounts of amino acids with positive
nitrogen balance (5). The problem, however, is just what kinds of amino acid
mixture are beneficial in the nutritional therapy of patients with advanced hepatic
disease.
Our previous study indicated that elevated levels of serum aromatic amino
acids could be significantly reduced with restoration of the normal molar ratio of
(valine + leucine + isoleucine)/(phenylalanine + tyrosine) (abbreviated below
to BCAA/AAA) by infusion of only 3 branched chain amino acids (1). We
prepared a new mixture of branched chain amino acids containing glutamate,
aspartate and ornithine (Hep-OU) for the present study. A commercially avail-
able amino acid solution and another amino acid mixture high in branched chain
amino acids and low in aromatic amino acids (Fischer solution) (6) were also
infused to patients with severe hepatic disease. The effect of each of the 3 types
of amino acid mixture on serum aminograms, biochemical parameters in the
blood and electroencephalograms was compared.
SUBJECTS AND METHODS
The subjects studied were 11 control subjects, 17 patients with non-malignant cir-
rhosis of the liver, 3 with fulminant hepatitis and 2 with subacute hepatitis. These
patients had been admitted to the Okayama University, Saiseikai General and
Kumayama Hospitals over a 3-year period. Diagnosis was based on liver biopsy
and autopsy findings as well as the clinical picture in 3 cases of liver cirrhosis and
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1 of subacute hepatitis. The mean grade of encephalopathy and electroencephalo-
graphic findings was based on Sherlock's (7) and Parsons-Smith's (8) classifications,
respectively. Quantitative determinations of serum amino acids were carried out
by a Nihon-Denshi ]CL-6AH amino acid analyzer as described previously (1).
Blood ammonia was assayed according to the methods of Fujii and Okuda (9) and
Seligson and Hirahata (10), and other biochemical analyses of blood were per-
formed according to routine laboratory methods (1). Nitrogen balance was deter-
mined by the Kje1dahl method (11).
The three solutions of amino acid mixture in a volume of 500 ml are shown
in Table 1. These solutions contain 100 g glucose, which was added just before
TABLE 1. COMPOSITION OF AMINO ACID SOLUTIONS
Commercially FischerAmino acids available
solution Hep-OU
amino acids
(g/500ml)
Leucine* 2.28 3.30 4. 15
Valine* 1. 38 2.50 3.05
Isoleucine* 1. 19 2. 70 2. 75
Methionine* 0.87 0.30
Cystine 0.05
Phenylalanine* 1. 95 0.30
Tyrosine 0.11
Tryptophan* 0.37 0.23
Threonine* 1. 01 1. 35
Lysine* 1. 57 2.28
Arginine 2.46 1. 80
Histidine 1.04 O. 70
Alanine 1. 64 2.25
Aspartic Acid 0.40 1. 00
Glutamic acid 0.20 1. 50
Glycine 3.14 2. 70
Proline 2. 13 2.40
Serine 0.93 1. 50
Cysteine O. 12
Ornithine 0.50
Total 22.72 24.43 12.95
----------
----------_._---
* Essential amino acids
the start of the infusion. The solutions were infused intravenously over a 3 h
period (2.8 ml/min or 0.56 g glucose/min) early in the morning. Parenteral nutri-
tion through a superior vena cava catheter was performed in patients with cir-
rhosis of the liver (Case N.F.) and subacute hepatitis (Case S.K.). Infusion to Case
N.F. was maintained at 1.2 g of protein/kg body weight/day and at about 90 non-
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protein Caloriesfg of nitrogen. Hep-OU or Fischer solution was infused daily
with glucose to Case S.K. for only a 3 h period each morning. In the rest of the
time, 20% glucose was given continuously with 0.3-0.5 g protein/kg body weightf
day. The clinical details of these patients are described in the Results section.
RESULTS
Serum amino acid levels in patients with hepatic disease. Amino acid analyses
of cirrhotic patients with and without hepatic encephalopathy consistently re-
vealed elevated levels of aromatic amino acids and methionine, together with de-
pressed values of 3 branched chain amino acids (Table 2). Methionine, tyrosine
TABLE 2. MEAN SERUM AMINO ACID LEVELS IN NORMAL SUBJECTS AND
PATIENTS WITH HEPATIC DISEASE
-----
Amino acid Amino acid level (,umoles/l)
Normal subject Liver cirrhosis Fulminant Subacute
hepatitis hepatitis
With Without
(5)
Encephalopathy
(2)(7) (3) (3)
Valine 208 ± 23 121 ± 10 lID ± 20 398 ± 107 142
Leucine 128 ± 13 69 ± 11 45 ± 8 270 ± III 74
Isoleucine 67 ± 7 45 ± 10 27 ± 3 92 ± 55 35
Methionine 30 ± 6 165 ± 58 59 ± 14 413 ± 121 318
Phenylalanine 68 ± 6 129 ± 16 107 ± 16 554 ± 181 164
Tyrosine 66 ± 5 178 ± 10 142 ± 10 383 ± 37 205
Tryptophan 87 ± 5 106 ± 6 106 ± 10 329 ± 69 89
Free tryptophan 6 ± 1 14 ± 2 7 ± 1 31 ± 6
BCAA/AAA 3.0 ± 0.3 0.8 ± 0.1 0.8 ± 0.2 0.8 ± O. 1 0.8
( ) ; No. of cases studied
and phenylalanine rose to a smaller extent in non-encephalopathic cirrhosis than
in encephalopathic cirrhosis. Other essential and nonessential amino acids were
either normal or only minimally changed All amino acids were markedly elevated
in patients with fulminant hepatitis, the results being greatly different from those
of cirrhotic patients. Two patients with subacute hepatitis showed a similar
pattern of serum amino acids to that found in fulminant hepatitis except for
decreased levels of the 3 branched chain amino acids. Elevated levels of free
tryptophan were observed in hepatic encephalophathic patients, but diminished
molar ratios of BCAA/AAA were found in most patients with hepatic disease.
No apparent correlation between free tryptophan levels and this molar ratio was
observed in encephalopathic patients. Markedly and mildly increased amounts
of 8 essential and 14 nonessential amino acids in serum were observed in patients
4
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with fulminant and subacute hepatitis but patients with cirrhosis and encephalo-
pathy showed minimally elevated levels of nonessential amino acids.
Infusion of a commercially available synthetic amino acid mixture to cirrhotic
patients. After infusion of a commercially available amino acid solution to a
cirrhotic patient, marked decreases in branched chain amino acids and elevations
of methionine, phenylalanine and tyrosine occurred 3 h after the end of a 3 h-
infusion, indicating that the commercially available amino acid mixture not only
failed to correct serum amino acid imbalance but also induced aminograms
similar to those obtained in hepatic encephalopathy (Fig. 1). The continuous in-
fusion of a commercially available amino acid solution to Case N.F. was carried
out under the conditions described in Subjects and Methods (Fig. 2). Case N.F., a
Relative % of initial concentration
o 100 200
Arginine
Methio[1ine
Tyrosine
Phenylalanine
Valine
Leucine
Isoleucine
Fig. 1. Effect of infusion of a commercially available amino acid mixture on serum
amino acid levels in a control subject and a patient with liver cirrhosis. Infusion of a com-
mercially available amino acid solution containing 100 g glucose/500 ml was performed during
3 h to a normal subject (26-year-old male, O···O), as described under Subjects and Methods,
and a patient with histologically proven cirrhosis (e-e, 54-year-old male) who was well
compensated with a normal level of blood ammonia. The blood for analysis of serum amino
acid levels was drown 3 h after the end of infusion.
61-year-old male, was admitted on March 4 because of abdominal distension and
hematemesis. He was given a blood transfusion immediately. Endoscopic ex-
amination indicated esophageal varices and gastric ulcers. The level of alpha-
fetoprotein (AFP) was higher than 1280 ng/ml, but hepatoma could not be
confirmed by liver scintigram, angiography or Pap smears of ascites cells.
He was diagnosed clinically as decompensated cirrhosis of the liver. Bleeding
from the upper gastrointestinal tract continued intermittently from May 20.
There was no good urinary response to furosemide, and ascites increased gradu-
ally. This was tapped frequently. His therapy consisted of nothing by mouth
and total parenteral nutrition using a commercially available amino acid-dextrose
mixture from June 11 to 18. Methionine and phenylalanine levels increased,
brG\llched chain amino acids remained unchanged, and the molar ratio of BCAA/
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Fig. 2. Clinical course in a patient with cirrhosis of the liver (Case N.F.) undergoing
long-term infusion of a commercially available amino acid mixture.
AAA decreased. The nitrogen balance became positive from the 2nd day of
parenteral nutrition. Bleeding continued and his level of consciousness gradually
decreased. This was accompanied by abnormal electroencephalographic findings
and he died on June 18.
Effect of Fischer solution on serum amino acid levels in a control subject and a
cirrhotic patient. Amino acids increased immediately after the end of a 3 h-
infusion of the Fischer solution to a control subject were threonine, proline,
glycine, alanine, ornithine, lysine, histidine, arginine and the 3 branched chain
amino acids (Fig. 3). Serum aminograms reflected the composition of the amino
acid solution infused. However, aspartate, glutamate, methionine, phenylalanine
6
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Fig. 3. Effect of infusion of Fischer solution on serum amino acid levels in a control sub-
ject. Infusion of Fischer solution with 100 g glucose was similarly carried out for a healthy
63-year-old man. Amino acid analyses were performed immediately (0-0) and 3 h (e-el
after the end of 3 h-infusion, in the same way as for Figs. 4-6.
Fig. 4. Effect of infusion of Fischer solution on serum amino acid levels in a patient with
cirrhosis of the liver. A 59-year-old housewife with cirrhosis of the liver who was kept on
a protein-restricted diet (about 30 g/day) for a long time because of blood ammonia levels of
150-200 flg/dl. Diagnosed by liver biopsy 2.5 years ago as chronic hepatic coma according to
Sherlock's classification (7). Hepatic encephalopathy occurred at a frequency of 2 or 3 times
a year, but consciouness was clear at the time of infusion.
and tyrosine levels were all markedly decreased both immediately after, and 3h
after, the end of infusion. Branched chain amino acids also showed lower levels at
3 h after infusion. In one case of liver cirrhosis with chronic encephalopathy (7),
strikingly elevated serum levels of the amino acids in the amino acid solution
given were observed immediately after the end of the infusion (Fig. 4). Many
amino acids including methionine, tyrosine and phenylalanine tended to decrease
3 h after the end of infusion. When the solution contained even small quantities
of methionine and phenylalanine, their levels rose temporarily but markedly to
200-300% of the initial levels immediately after the end of infusion. Methionine
levels has only fallen slightly even 3 h after the end of the infusion. This is a
marked difference from the results for the control subjects.
Effect of Hep-OU on serum amino acid levels in a control subject and a cirrhotic
patient. Our previous report has shown that amino acids decreased after infusion
7
Watanabe et al.: An approach to nutritional therapy of hepatic encephalopathy by n
Produced by The Berkeley Electronic Press, 1978
434 A. WATANABE et al.
of 3 branched chain amino acids were members associated with the urea cycle,
particularly aspartate, glutamate and ornithine (I). Small quantities of these 3
Relative" of initial concentration
200
Taurine Taurine
Aspartic acid Aspartic acid
Threonine Threonine
Serine Serine
Asparagine Asparagine
Glutamic acid Glutamic acid
Glutamine Glutamine
Proline Proline
Glytine Glycine
Alanine Manine
Cystine Cystine
Ornithine Ornithine
lysine lysine
Histidine Histidine
Arginine Ar'(jinine
Methionine Nlethionine
Tyrosine Tyrosine
Phenylalanine Phenylalanine
Valine
,1:: ValineLeucine LeucineIsoleucine Isoleucine
Relative % of initial concentration
Fig. 5 Fig. 6
Fig. 5. Effect of Hep-OU infusion on serum aminograms in a control subject. Infusion
of Hep-OU with 100 g glucose was similarly performed in the same way for a control sub-
ject, a 58-year-old housewife.
Fig. 6. Effect of Hep-OU infusion on serum amino acid levels in a patient with cirrhosis
of the liver. A 45-year-old man with cirrhosis who was well compensated and took a daily
protein intake of 70 g. Blood ammonia levels were 90-120 ,ug/dl. Diagnosed on clinical find-
ings.
amino acids were added to prepare Hep-OU solution. Serum aminograms both
immediately after, and 3 h after, the end of a Hep-OU infusion were better than
those after infusion of the previously prepared solution of 3 branched chain
amino acids alone; that is the reduction of aspartate, glutamate and ornithine
was prevented. Moreover, tyrosine, methionine and phenylalanine diminished
similarly to 5-40 % of the initial value (Fig. 5). Amino acid levels in a patient
with cirrhosis of the liver were mildly depressed or elevated following Hep-OU
infusion except that marked elevations of branched chain amino acids and greatly
diminished levels of methionine and phenylalanine were observed immediately
after, and 3 h after, the infusion, respectively (Fig. 6). Marked fluctations in
other amino acid levels after Hep-OU infusion were not observed in a cirrhotic
patient. Diminished levels of methionine, tyrosine and phenylalanine were
similar to those obtained with Fischer solution. The blood ammonia level fell
slightly and the previously elevated levels of serum. nonesterified fatty acids
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(NEFA) returned to normal values after infusion of this solution. A marked
response of insulin to the administration of amino acid-glucose mixture occurred
in one patient with cirrhosis. Changes in the molar ratio of BCAA/AAA after
the infusion of different types of amino acid solutions are summarized in Fig. 7.
Diminished ratios in patients with liver cirrhosis returned to control values and
remained within normal limits for at least 6 h after the start of Hep-OU or
Fischer solution. These results are different from those obtained by infusion of a
commercially available amino acid mixture.
Cirrtlotic p3tients
~.
b--~
o 3 6 0 3 6
Hours after administration
Control subiects
10
+ ~
'0>-
>1-
~ +
'01: 5
.~~
'"o
2:
Fig. 7. Change in the molar ratio of BCAA/AAA following infusion of a solution of
3 types of amino acid mixture. A commercially available amino acid solution, .; Fischer
solution, 0 and Hep-OU, @.
Clinical and neurological improvements following infusion of Hep-OU and Fischer
solution to patients with subacute hepatitis and liver cirrhosis. Case S.K., a 51-year-
old housewife, was admitted on June 28 complaining of anorexia and deep
jaundice of a week's duration. She had had previous episodes of jaundice with
marked elevation of serum transaminase activities for 20 days from the end of
February to March and again for 10 days in April. Prednisolone had been ad-
ministered almost continuously from the end of February. Serum bilirubin rose
gradually to 27 mg/dl and GPT activities varied from 780 to 1090 during the
first 3 weeks after admission. Even with the introduction of steroid therapy from
the 3rd week, there was no prompt improvement in serum bilirubin levels.
Total parenteral nutrition with about 1500 Calories/day was started from June
20. The serum bilirubin rose to 40 mg/dl and disseminated intravascular coagu-
lation developed. She died on July 26 despite the administration of large quan-
tities of heparin. Her consciousness remained relatively clear till death, although
electroencephalographic fiindings showed severe cerebral disfunction. Serum
aminograms and electroencephalographic findings after infusion of Hep-OU
(July 20) or Fischer solution (July 21) are shown in Table 3 and Fig. 8. The
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changes in serum levels of several amino acids with time are also shown (Table
3). Further abnormal aminograms were found immediately after infusion of
Fischer solution and seem to be related to the amino acid composition of the
solution infused. Decreases in methionine, tyrosine and phenylalanine after
infusion of either splution were again small in this case as compared with those in
cirrhotic patients. Levels of the 3 branched chain amino acids rose, then fell and
~~~
If 1 2
~~
-;)~~~~~~~-
~
I""""~
a 4
~~
Fig. 8. Change in electroencephalographic findings in a patient with cirrhosis of the liver
(Case U.K.) following Hep-GU infusion. Electroencephalographic findings before and after
Hep-GU are illustrated. 1, Before; 2, immediately after; 3,3 h following the end of Hep-GU
(December 23); and 4, the morning of December 24.
TABLE 3. CHANGES OF SERUM AMINO ACID LEVELS IN A PATIENT WITH SUBACUTE
HEPATITIS AFTER INFUSION OF HEP-au AND FISCHER SOLUTION
Solution Time after Amino acid level (/lmoles/l)
the start
of infusion Valine Leucine Isoleu- Methio- Tyrosine Phenyl- BCAA/AAA(Hour) cine nine alanine
Hep-GU (july 20)
0 106 76 54 508 228 140 0.6
3 351 316 158 478 162 78 3.4
6 116 46 26 439 144 61 0.9
Fischer (july 21)
0 46 22 27 429 178 79 0.4
3 366 196 189 524 151 93 3.1
6 146 56 39 475 159 110 1.0
10
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continued to decrease below the initial levels till the next morning. Continuous
administration during 24 h of branched chain amino acids would be necessary to
maintain these amino acids within normal ranges. Two to three cis of basic
activities with triphasic waves (Grade E) were continuously observed before
infusion of Hep-OU on July 20. The basic activities became 5-6 cis immediately
after, and 4-5 cis (Grade D) 3 h after, the end of the infusion. Some slow a
waves appeared (Grade C) immediately after the end of Fischer solution and e
waves reappeared thereafter.
Case U.K., a 63-year-old male, entered the hospital on May 30 because of
drowsiness. He was diagnosed as hepatic encephalopathy from clinical and
laboratory findings 4 years earlier. Encephalopathic episodes (mostly Grade 2)
had occurred 2-6 times in a year without any specific cause. These usually re-
covered gradually over a period of 3-6 days. Elevated levels of blood ammonia
are at present considered unrelated to the occurrence of hepatic encephalopathy.
He became drowsy on October 8 and suddenly lapsed into deep coma on October
9. L-DOPA, steroid hormones and arginine-glutamate mixture were injected
but proved ineffective. Two h after the commencement of an infusion of Hep-
au (500 ml of 10% glucose) on the morning of October 10, the patient awakened
from the hepatic encephalopathy. Consciousness was completely normal by the
end of a 3 h-infusion. The aminogram 2.5 h after the end of the 2nd infusion of
Hep-OU was compared with that at the time of hepatic encephalopathy (Grade
4) on November 3. Levels of phenylalanine, tyrosine and branched chain amino
acids as well as the molar ratio of BCAA/AAA were well within normal limits
but the methionine level was very low after the Hep-OU infusion on October 10.
The serum aminogram on November 3 indicated a molar ratio of 0.5 with ex-
tremely low levels of branched chain amino acids and slightly elevated levels of
TABLE 4. CHANGES OF SERUM AMINO ACID LEVELS IN A PATIENT WITH LIVER
CIRRHOSIS AFTER INFUSION OF HEP-OU
Amino acid
October 10
Amino acid level (pmoles/l)
---
November 3 November 4
Before Hep-OU 3 Hours after the
end of Hep-OU
Valine 225 42 253 116
Leucine 107 14 84 42
Isoleucine 64 15 61 33
Methionine 0.2 17 8 20
Tyrosine 70 86 55 60
Phenylalanine 59 67 45 57
BCAA/AAA 3.1 0.5 4.0 1.6
11
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tyrosine. Encephalopathy again improved rapidly by Hep-OU infusion alone,
the ratio being 4.0 3 h after the end of the infusion. In the encephalogram, a
slower basic activity was found than before the Hep-OU infusion on December
~3 (Fig. 8). Electroencephalograms changed to a basic activity of 5-6 cis slow
a waves immediately after, and 3 h after, the end of the infusion. The improve-
ment was still present the next morning.
DISCUSSION
Patients with advanced liver disease frequently develop severe malnutrition
and marked imbalance of serum amino acids. So far, there has been little success
in correcting these abnormalities of amino acid levels, which are thought to be
related to poor utilization or rapid turnover of amino acids and to the negative
nitrogen balance of the catabolic state (12). Administration of a commercially
available mixture of nonessential and essential amino acids to cirrhotics resulted
in a strikingly abnormal serum amino acid pattern with a lowered molar ratio of
BCAAIAAA. Continuous infusion of a commercially available amino acid mix-
ture to Case N.F. in amounts equivalent to 72 g of protein every 24 h also re-
sulted in elevated levels of aromatic amino acids without restoration of branched
chain amino acid levels. This picture has been associated with the onset of
hepatic encephalopathy. The levels of neurotransmitters mediating central nerv-
ous system function may be controlled by serum amino acids, particularly neutral
amino acids (2). If abnormal amino acid patterns are related to hepatic encepha-
lopathy, normalization of serum amino acid imbalance would be of prime im-
portance and beneficial in the treatment of neurological abnormalities.
In fact, preliminary results in patients with hepatic encephalopathy of
various etiologies have already suggested that parenteral nutrition using a solu-
tion of amino acid mixture high in branched chain amino acids and low in
aromatic amino acids apparently improve central nervous system function (13).
Our previous results indicated that infusion of only 3 branched chain amino acids
was effective in reducing aromatic amino acid levels but that it caused a decrease
in amino acids associated with the urea cycle. Based on these results, glutamate,
aspartate and ornithine were added in small amounts to the previous solution of
3 branched chain amino acids in order to prevent the striking reduction of these
amino acids. This solution apparently caused decreased levels of methionine,
tyrosine and phenylalanine in a control subject and in patients with liver cirrhosis
or subacute hepatitis. However, a marked elevation in many amino acids as
well as methionine and phenylalanine was markedly elevated immediately after
infusion of Fischer solution to patients with cirrhosis of the liver and subacute
hepatitis. Therefore, Hep-OU may be safe and useful in the treatment of hepa-
tic encephalopathy. This solution ~lone should not be used for a long period
12
Acta Medica Okayama, Vol. 32 [1978], Iss. 6, Art. 7
http://escholarship.lib.okayama-u.ac.jp/amo/vol32/iss6/7
Hepatic Encephalopathy and Amino Acid Infusion 439
because its composition of amino acids is not nutritionally adequate. Parenteral
nutritional supplement with a specially designed amino acid mixture should be
started as early as possible in the presence of diminishing oral dietary intake.
Otherwise the catabolic state of the cirrhotic patient may precipitate upper
gastrointestinal bleeding, infection and electrolyte imbalance, easily bringing
about hepatic encephalopathy. The total amounts of amino acid to be adminis-
tered should be decided by measuring daily nitrogen balance.
A clinical problem frequently encountered is that the nutrient infusion
volume has to be greatly restricted because of oliguria in advanced cirrhosis.
Autogeneous and concentrated ascitic fluid may have to be reused by mixing
large amounts of glucose and amino acids in cirrhotic patients with intractable
ascites or hepatorenal syndrome. Commercially available mixtures of essential
and nonessential amino acids were not tolerated in advanced cirrhotic patients,
even in amounts of up to 20 g/day. However, administration of a modified solu-
tion up to 100 g protein equivalents every 24 h is possible and has even been
associated with improvements in hepatic function (14). The technique of paren-
teral nutrition can be widely applied in patients with advanced cirrhosis of the
liver and studies of this technique should clarify the pathophysiology of hepatic
encephalopathy.
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